BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21050441)

  • 1. Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cells.
    Navarra M; Celano M; Maiuolo J; Schenone S; Botta M; Angelucci A; Bramanti P; Russo D
    BMC Cancer; 2010 Nov; 10():602. PubMed ID: 21050441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
    Molinari A; Fallacara AL; Di Maria S; Zamperini C; Poggialini F; Musumeci F; Schenone S; Angelucci A; Colapietro A; Crespan E; Kissova M; Maga G; Botta M
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3454-3457. PubMed ID: 30262428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner.
    Hishiki T; Saito T; Sato Y; Mitsunaga T; Terui E; Matsuura G; Saito E; Shibata R; Mise N; Yokoyama Y; Yoshida H
    Pediatr Surg Int; 2011 Feb; 27(2):225-30. PubMed ID: 21046121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
    Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F
    Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
    Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
    Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
    Tu Y; Cheng S; Zhang S; Sun H; Xu Z
    Int J Mol Med; 2013 Jan; 31(1):113-9. PubMed ID: 23129065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells.
    Spreafico A; Schenone S; Serchi T; Orlandini M; Angelucci A; Magrini D; Bernardini G; Collodel G; Di Stefano A; Tintori C; Bologna M; Manetti F; Botta M; Santucci A
    FASEB J; 2008 May; 22(5):1560-71. PubMed ID: 18171692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells.
    Radi M; Brullo C; Crespan E; Tintori C; Musumeci F; Biava M; Schenone S; Dreassi E; Zamperini C; Maga G; Pagano D; Angelucci A; Bologna M; Botta M
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5928-33. PubMed ID: 21856155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
    Tintori C; Fallacara AL; Radi M; Zamperini C; Dreassi E; Crespan E; Maga G; Schenone S; Musumeci F; Brullo C; Richters A; Gasparrini F; Angelucci A; Festuccia C; Delle Monache S; Rauh D; Botta M
    J Med Chem; 2015 Jan; 58(1):347-61. PubMed ID: 25469771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exogenous antizyme 1 gene transfection inhibits proliferation and promotes apoptosis of human neuroblastoma SH-SY5Y cells in vitro].
    Jiang L; Ma WL; Li J; Peng YF; Xu B; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1709-13. PubMed ID: 18024296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a variant which has reduced Src activity from SH-SY5Y neuroblastoma cells.
    Hiwasa T; Nakamura Y; Sakiyama S
    Anticancer Res; 1998; 18(5A):3311-4. PubMed ID: 9858901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
    Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 14. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.
    Rossi A; Schenone S; Angelucci A; Cozzi M; Caracciolo V; Pentimalli F; Puca A; Pucci B; La Montagna R; Bologna M; Botta M; Giordano A
    FASEB J; 2010 Aug; 24(8):2881-92. PubMed ID: 20354138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells.
    Gao B; Shi HL; Li X; Qiu SP; Wu H; Zhang BB; Wu XJ; Wang ZT
    Life Sci; 2014 Jul; 108(2):63-70. PubMed ID: 24857982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
    Bieerkehazhi S; Chen Z; Zhao Y; Yu Y; Zhang H; Vasudevan SA; Woodfield SE; Tao L; Yi JS; Muscal JA; Pang JC; Guan S; Zhang H; Nuchtern JG; Li H; Li H; Yang J
    Oncotarget; 2017 Jan; 8(1):1469-1480. PubMed ID: 27903968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation.
    Carraro F; Naldini A; Pucci A; Locatelli GA; Maga G; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Modugno M; Tintori C; Manetti F; Botta M
    J Med Chem; 2006 Mar; 49(5):1549-61. PubMed ID: 16509573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.
    Kong L; Deng Z; Shen H; Zhang Y
    Mol Cell Biochem; 2011 Feb; 348(1-2):11-9. PubMed ID: 21052789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.
    Cozzi M; Giorgi F; Marcelli E; Pentimalli F; Forte IM; Schenone S; D'Urso V; De Falco G; Botta M; Giordano A; Indovina P
    Cell Cycle; 2012 Mar; 11(5):1029-39. PubMed ID: 22333592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.